Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MOREWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MOREUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don’t find the answers you’re looking for, contact us for additional assistance.
EXPLORE MORE
Besides various cancers, Creative Biolabs also provides customer with CellRapeutic™ Chimeric Antigen Receptor (CAR) products targeting viral antigens and viral-associated cancer antigens. Here, we now offer customer cutting edge CAR-T products targeting a range of viral antigens arising from Epstein–Barr virus (EBV), Cytomegalovirus (CMV), and Adenovirus (Adv).
The EBV, also known as human herpesvirus 4 (HHV-4), is one of the eight viruses in herpes family, and is one of the most common viruses in human. Infection with EBV is associated with several cancers like Hodgkin's lymphoma, Burkitt's lymphoma, gastric cancer, nasopharyngeal carcinoma, and certain autoimmune diseases such as dermatomyositis, systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome and multiple sclerosis. The Cytomegalovirus (CMV), also known as human herpesvirus-5 (HHV-5), is a kind of viruses in the Herpesviridae family. CMV infection is a common incident that can affect any people. There's no efficient treatment for CMV, however, compounds can help treat newborns and individuals with weak immune systems.
Products ordering information
If you need any information, please don't hesitate to contact with us at anytime.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.
LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MORE
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE
